πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 22 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10683363

Targeting intracellular target-binding determinants with intracellular antibodies

The United States of America as represented by the Department of Veteran Affairs Β· Granted Tue Jun 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10335365

Bladder cancer specific ligand peptides

The United States of America as represented by the Department of Veteran Affairs (Washington DC) Β· Granted Tue Jul 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10322125

TGF-beta enhancing compositions for cartilage repair and methods related thereto

The United States of America as represented by the Department of Veteran Affairs Β· Granted Tue Jun 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10166244

Targeting NCCA-ATP channel for organ protection following ischemic episode

The United States of America as represented by the Department of Veteran Affairs Β· Granted Tue Jan 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9801865

Materials and methods for diagnosis, prevention and/or treatment of stress disorders and c

The United States of America as represented by the Department of Veteran Affairs Β· Granted Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9789162

Systemic and local ex vivo gene therapy of the skeleton

The United States of America as represented by the Department of Veteran Affairs Β· Granted Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9598441

Therapeutic compounds and methods

The United States of America as represented by the Department of Veteran Affairs Β· Granted Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9546151

VMAT inhibitory compounds

The United States of America as represented by the Department of Veteran Affairs Β· Granted Tue Jan 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9458215

Compositions and methods for osteogenic gene therapy

The United States of America as represented by the Department of Veteran Affairs Β· Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9173917

Methods for reducing oxidative stress in a cell with a sulfhydryl protected glutathione pr

The United States of America as represented by the Department of Veteran Affairs Β· Granted Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8961989

Methods for producing an immune response to tuberculosis

The United States of America as represented by the Department of Veteran Affairs Β· Granted Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8895018

Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric imp

The United States of America as represented by the Department of Veteran Affairs Β· Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8858930

Live attenuated bacterial vaccine to reduce or inhibit carriage and shedding of enterohemo

The United States of America as represented by the Department of Veteran Affairs Β· Granted Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8802835

Proteins with repetitive bacterial-Ig-like (Big) domains present in leptospira species

The United States of America as represented by the Department of Veteran Affairs Β· Granted Tue Aug 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8569377

Methods for treating spinal cord injury with a compound that inhibits a NCCA-ATP channel

The United States of America as represented by the Department of Veteran Affairs Β· Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8440206

Methods for producing an immune response to tuberculosis

The United States of America as represented by the Department of Veteran Affairs Β· Granted Tue May 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8153156

Hydrogel nanocompsites for ophthalmic applications

The United States of America as represented by the Department of Veteran Affairs Β· Granted Tue Apr 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8021671

Pro-apoptotic bacterial vaccines to enhance cellular immune responses

The United States of America as represented by the Department of Veteran Affairs Β· Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7173007

Therapy for microbial infections

The United States of America as represented by the Department of Veteran Affairs Β· Granted Tue Feb 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 6897227

Prodrugs of proton pump inhibitors

The United States of America as represented by the Department of Veteran Affairs Β· Granted Tue May 24 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6559167

Prodrugs of proton pump inhibitors

The United States of America as represented by the Department of Veteran Affairs Β· Granted Tue May 06 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6552006

Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen

The United States of America as represented by the Department of Veteran Affairs Β· Granted Tue Apr 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired